PCN83 Cost-effectiveness analysis of histamine dihydrochloride + low dose interleukin-2 vs standard of care for acute myeloid leukemia patients in their first complete remission: a UK perspective [Abstract]

Magar, R. S., Purdy, C., Hayward, A., Einarson, T. R. and Burnett, Alan Kenneth 2009. PCN83 Cost-effectiveness analysis of histamine dihydrochloride + low dose interleukin-2 vs standard of care for acute myeloid leukemia patients in their first complete remission: a UK perspective [Abstract]. Value in Health 12 (7) , A272. 10.1111/j.1524-4733.2009.00592_2.x

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Additional Information:	ISPOR Twelfth Annual European Congress Research Poster Abstracts
Publisher:	Wiley-Blackwell
ISSN:	1098-3015
Last Modified:	25 Jun 2017 02:41
URI:	https://orca.cardiff.ac.uk/id/eprint/18018

Actions (repository staff only)

Edit Item